6854-07-5

Basic information

• Product Name: 2-Hydroxy-5-nitronicotinic acid
• Synonyms: 2-HYDROXY-5-NITRO-3-PYRIDINECARBOXYLIC ACID;2-HYDROXY-5-NITRONICOTINIC ACID;2-HYDROXY-5-NITROPYRIDINE-3-CARBOXYLIC ACID;2-HYDRO-5-NITRONICOTINIC ACID;2-Hydroxy-5-nitronicotinic acid 98%;2-Hydroxy-3-carboxy-5-nitropyridine ;2-Hydroxy-5-nitropyridine-3-carboxylic acid ,98%;2-Hydroxy-5-nitronicotinic acid ,98%
• CAS NO: 6854-07-5
• Molecular Formula: C₆H₄N₂O₅
• Molecular Weight: 184.11
• Product Categories: blocks;Carboxes;NitroCompounds;Pyridines;Pyridines, Pyrimidines, Purines and Pteredines;Carboxylic Acids;Carboxylic Acids
• Mol File: 6854-07-5.mol
• Article Data: 14

Chemical Properties

• Melting Point: 236-240
• Boiling Point: 375.1ºC at 760 mmHg
• Flash Point: 180.6ºC
• Appearance: /
• Density: 1.70±0.1 g/cm3(Predicted)
• Vapor Pressure: 1.17E-06mmHg at 25°C
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 1.83±0.20(Predicted)
• CAS DataBase Reference: 2-Hydroxy-5-nitronicotinic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Hydroxy-5-nitronicotinic acid(6854-07-5)
• EPA Substance Registry System: 2-Hydroxy-5-nitronicotinic acid(6854-07-5)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-37/39
• HazardClass: IRRITANT
• Hazardous Substances Data: 6854-07-5(Hazardous Substances Data)

Usage

Chemical Properties

White solid

InChI:InChI=1/C6H4N2O5/c9-5-4(6(10)11)1-3(2-7-5)8(12)13/h1-2H,(H,7,9)(H,10,11)/p-1

Upstream product

• 609-71-2 2-hydroxy-3-carboxypyridine 
• 6760-14-1 2-amino-5-nitro-nicotinic acid 
• 265664-09-3 2-ethoxy-5-nitro-nicotinonitrile 
• 5345-47-1 2-aminopyridin-3-carboxylic acid 
• 31309-08-7 2-chloro-5-nitropyridine-3-carbonitrile 
• 31309-38-3 2-hydroxy-5-nitronicotinonitrile 

Downstream Products

• 5418-51-9 5-nitro-2-hydroxypyridine 
• 134894-60-3 6,9-dimethyl-3-nitropyrido<2,3-b><1,5>benzoxazepin-5(6H)-one 
• 134894-58-9 N-(2-hydroxy-4-methylphenyl)-2-chloro-5-nitro-3-pyridinecarboxamide 
• 140413-21-4 2-Amino-10-ethyl-7,8-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one 
• 140413-22-5 2-Amino-10-isopropyl-7,8-dimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one 
• 140413-20-3 2-Amino-7,8,10-trimethyl-10H-5-oxa-4,10-diaza-dibenzo[a,d]cyclohepten-11-one 
• 134894-45-4 3-amino-6,9-dimethylpyrido<2,3-b><1,5>benzoxazepin-5(6H)-one 
• 151323-46-5 ethyl 5-(acetylamino)-2-biphenyl-4-yl>methyl>amino>pyridine-3-carboxylate 
• 151323-45-4 ethyl 5-amino-2-biphenyl-4-yl>methyl>amino>pyridine-3-carboxylate 
• 157361-93-8 5-Nitro-2-{propyl-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-nicotinic acid ethyl ester 
• 151322-83-7 ethyl 2-chloro-5-nitro-3-pyridinecarboxylate 
• 288148-77-6 2-chloro-N-(2-hydroxy-5-nitro-phenyl)-5-nitro-nicotinamide 
• 60524-15-4 2-chloro-5-nitronicotinamide 
• 135795-55-0 2-chloro-3-chlorocarbonyl-5-nitropyridine 

Relevant articles and documents

METHODS OF TREATING AGITATION

The present disclosure relates generally to the treatment of agitation associated with neurodegenerative disorders.

AZAINDOLES AS INHIBITORS OF SOLUBLE ADENYLATE CYCLASE

The present invention relates to azaindoles of general Formula (I), a method for the production thereof, and to the us e thereof for the production of pharmaceutical compositions.

NOVEL ANXIOLYTIC COMPOUNDS

The present invention relates to chemical compounds of general formula (I) which may possess useful therapeutic activity in a range of central nervous system disorders, and in particular, anxiety disorders.